A detailed history of Legal & General Group PLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 251,371 shares of PACB stock, worth $439,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251,371
Previous 235,610 6.69%
Holding current value
$439,899
Previous $883,000 61.04%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.36 - $3.65 $21,434 - $57,527
15,761 Added 6.69%
251,371 $344,000
Q1 2024

May 14, 2024

SELL
$3.52 - $9.59 $2,330 - $6,348
-662 Reduced 0.28%
235,610 $883,000
Q4 2023

Feb 15, 2024

BUY
$5.97 - $10.36 $11,396 - $19,777
1,909 Added 0.81%
236,272 $2.32 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $62,021 - $104,976
7,536 Added 3.32%
234,363 $1.96 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $147,017 - $207,181
14,746 Added 6.95%
226,827 $3.02 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $179,102 - $271,135
22,557 Added 11.9%
212,081 $2.46 Million
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $35,533 - $70,190
-6,267 Reduced 3.2%
189,524 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $75,306 - $164,218
-19,162 Reduced 8.91%
195,791 $1.14 Million
Q2 2022

Aug 22, 2022

BUY
$4.02 - $10.43 $173,446 - $450,012
43,146 Added 25.11%
214,953 $950,000
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $35,026 - $86,839
4,155 Added 2.48%
171,807 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $1,502 - $2,346
78 Added 0.05%
167,652 $3.43 Million
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $796,763 - $1.12 Million
32,050 Added 23.65%
167,574 $4.28 Million
Q2 2021

Aug 12, 2021

BUY
$22.3 - $36.02 $242,467 - $391,645
10,873 Added 8.72%
135,524 $4.74 Million
Q1 2021

May 17, 2021

BUY
$26.38 - $51.15 $1.73 Million - $3.35 Million
65,572 Added 110.99%
124,651 $4.15 Million
Q4 2020

Feb 12, 2021

BUY
$10.5 - $28.5 $20,968 - $56,914
1,997 Added 3.5%
59,079 $1.53 Million
Q3 2020

Nov 13, 2020

SELL
$3.61 - $9.87 $14,317 - $39,144
-3,966 Reduced 6.5%
57,082 $563,000
Q2 2020

Aug 14, 2020

SELL
$2.65 - $4.03 $12,587 - $19,142
-4,750 Reduced 7.22%
61,048 $211,000
Q1 2020

May 14, 2020

SELL
$2.36 - $5.26 $15,453 - $34,442
-6,548 Reduced 9.05%
65,798 $202,000
Q4 2019

Feb 13, 2020

BUY
$4.6 - $5.57 $172,923 - $209,387
37,592 Added 108.17%
72,346 $372,000
Q3 2019

Nov 13, 2019

BUY
$4.99 - $6.16 $29,251 - $36,109
5,862 Added 20.29%
34,754 $179,000
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $11,034 - $13,812
1,864 Added 6.9%
28,892 $175,000
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $4,841 - $5,268
712 Added 2.71%
27,028 $196,000
Q4 2018

Feb 15, 2019

BUY
$3.99 - $7.82 $33,220 - $65,109
8,326 Added 46.28%
26,316 $195,000
Q2 2018

Aug 10, 2018

SELL
$2.11 - $3.92 $8,146 - $15,135
-3,861 Reduced 17.67%
17,990 $64,000
Q1 2018

May 17, 2018

SELL
$2.05 - $3.23 $7,968 - $12,555
-3,887 Reduced 15.1%
21,851 $45,000
Q4 2017

Feb 13, 2018

BUY
$2.59 - $5.44 $66,661 - $140,014
25,738
25,738 $68,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $393M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.